PUNE, India, November 17, 2016 /PRNewswire/ -- According to a new market research report "Respiratory Diagnostics Market - Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021", published by MarketsandMarkets, the global market is projected to reach USD 7.45 Billion by 2021 from USD 5.24 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021. (Logo: http://photos.prnewswire.com/prnh/20160303/792302 ) Browse 83 market data Tables and 39 Figures spread through 144 Pages and in-depth TOC on"Respiratory Diagnostics Market"http://www.marketsandmarkets.com/Market-Reports/respiratory-diagnostics-market-163390459.htmlEarly buyers will receive 10% customization on this report. Major factors driving the market growth are increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory diagnostic systems. On the other hand, rising healthcare costs and reimbursement concerns are the major factors restraining the growth of the Respiratory Diagnostics Market. High potential emerging markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore offer significant growth opportunities for the key players in the Respiratory Diagnostics Market. The global Respiratory Diagnostics Market is segmented on the basis of product and service, test type, disease, end user, and region. On the basis of product and service, the Respiratory Diagnostics Market is segmented into instruments and devices, assays and reagents, and software and services. The instruments and devices segment is expected to account for the largest share of the Respiratory Diagnostics Market in 2016. The continuous requirement of diagnostic instruments and devices in laboratories, point-of-care, and home care is a major factor driving the uptake of instruments and devices.